Teva Homepage Print this page Site Map
About TevaInvestor RelationsTeva Worldwide

Press Releases

Jerusalem, Israel, Lund, Sweden, February 8, 2010
Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regions

Jerusalem, February 5, 2010
Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits

Jerusalem, February 2, 2010
Teva Announces FDA Accepts BLA for XM02

Jerusalem, Israel, January 26, 2010
Teva Receives Favorable Court Decision Regarding Generic Temodar®

Jerusalem, Israel, January 22, 2010
Court of Appeals Affirms Favorable Decision Regarding Generic Prevacid® SoluTab

Jerusalem, Israel, January 21, 2010
Teva Announces Tentative Approval of Generic Femara® Tablets

Jerusalem, Israel, January 19, 2010
Teva to Donate Medicine to Haiti Earthquake Relief Effort

Jerusalem, Israel, January 19, 2010
Teva to Report Fourth Quarter and Full Year 2009 Financial Results on February 16, 2010

Jerusalem, Israel, January 14, 2010
Moody's Upgrades Teva Rating to A3

Jerusalem, Israel, January 8, 2010
Teva To Present At The 28th Annual J.P. Morgan Healthcare Conference

Jerusalem, Israel, January 7, 2010
Teva Presents Strategic Plan to Deliver Strong Growth

Jerusalem, Israel, January 7, 2010
Teva Announces Settlement Agreements With AstraZeneca Regarding Generic Prilosec® and Nexium®

Jerusalem, Israel, January 4, 2010
Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference



Archive:  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999